Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Elscint, Inc.

This article was originally published in The Gray Sheet

Executive Summary

Elscint, Inc.: Thomas Spackman, MD, resigns as president and CEO of the Hackensack, New Jersey-based Elscint Ltd. subsidiary, a position he has held since December 1993. Spackman will continue to serve on the firm's board of directors. Peter Annand is promoted to COO from senior-VP of operations, and Sandra Serrett-Curran is promoted to senior-VP from VP of finance, pending board approval. Annand and Serrett-Curran will oversee the duties previously handled by Spackman. "A decision will be made later in 1997 as to whether Elscint will appoint a new president and CEO," the firm says...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT007845

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel